Apimeds Pharmaceuticals Enters First Amendment To Settlement Agreement On Sept. 10; Board To Consist Solely Of Four Members During Interim Period; Board To Expand To Seven Members After Interim Period; Amends Settlement Agreement With Inscobee Parties
https://www.sec.gov/ix?doc=/Archives/edgar/data/1894525/000121390026099002/ea0305245-8k_apimeds.htm
Apimeds changed its agreement with another company and is temporarily running its board with four people instead of seven. When you see board changes like this, watch if the company can still make good decisions and move forward smoothly.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.